Literature DB >> 16611117

Antiviral drug discovery targeting to viral proteases.

John T A Hsu1, Hsiang-Ching Wang, Guang-Wu Chen, Shin-Ru Shih.   

Abstract

Proteases fulfill multiple roles in health and disease, and considerable interest has been expressed in the design and development of synthetic inhibitors of disease-related proteases. Virus-encoded proteases have been shown to be involved in the replication of many viruses. The success of anti-HIV-1 therapy using specific and potent protease inhibitors suggests that viral proteases can be the valid molecular targets for the development of antiviral drugs against other viruses. Intensive genetic and biochemical studies have been conducted on viral proteases and new insights and results are rapidly emerging. This work reviews features of viral proteases with respective to the development of effective antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611117     DOI: 10.2174/138161206776361110

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  12 in total

1.  Anthracene-based inhibitors of dengue virus NS2B-NS3 protease.

Authors:  Suzanne M Tomlinson; Stanley J Watowich
Journal:  Antiviral Res       Date:  2010-12-23       Impact factor: 5.970

2.  Transcription factor PrtT controls expression of multiple secreted proteases in the human pathogenic mold Aspergillus fumigatus.

Authors:  Haim Sharon; Shelly Hagag; Nir Osherov
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

3.  Study of the Interaction of Novel Nonprotein Amino Acids with Trypsin by Steady-State Fluorescence Spectroscopy.

Authors:  Gohar A Shahinyan; Ani S Dadayan; Nelli A Hovhannisyan; Shiraz A Markarian
Journal:  J Fluoresc       Date:  2020-02-12       Impact factor: 2.217

4.  Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins.

Authors:  Adam J T Smith; Xiyun Zhang; Andrew G Leach; K N Houk
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

5.  Functional domains of the HK97 capsid maturation protease and the mechanisms of protein encapsidation.

Authors:  Robert L Duda; Bonnie Oh; Roger W Hendrix
Journal:  J Mol Biol       Date:  2013-05-17       Impact factor: 5.469

6.  Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer.

Authors:  Meng-Tian Tsai; Yun-Hsiang Cheng; Yu-Ning Liu; Nien-Chien Liao; Wen-Wen Lu; Szu-Hao Kung
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

7.  Rational design of novel red-shifted BRET pairs: Platforms for real-time single-chain protease biosensors.

Authors:  Seth T Gammon; Victor M Villalobos; Mikhail Roshal; Mustapha Samrakandi; David Piwnica-Worms
Journal:  Biotechnol Prog       Date:  2009 Mar-Apr

8.  Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain.

Authors:  Assaf Shapira; Meital Gal-Tanamy; Limor Nahary; Dana Litvak-Greenfeld; Romy Zemel; Ran Tur-Kaspa; Itai Benhar
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

Review 9.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

10.  Removal of hepatitis C virus-infected cells by a zymogenized bacterial toxin.

Authors:  Assaf Shapira; Shiran Shapira; Meital Gal-Tanamy; Romy Zemel; Ran Tur-Kaspa; Itai Benhar
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.